Quality Assessment of Patient-Facing Urologic Telesurgery Content Using Validated Tools

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Introduction : With increasing accessibility to Artificial Intelligence (AI) chatbots, the precision and clarity of medical information provided requires rigorous assessment. Urologic telesurgery represents a complex concept that patients will investigate using AI. We compared ChatGPT and Google Gemini in providing patient-facing information on urologic telesurgical procedures. Methods : 19 questions related to urologic telesurgery were generated using general information from the American Urologic Association (AUA) and European Robotic Urology Section (ERUS). Questions were organized into 4 categories (Prospective, Technical, Recovery, Other) and directly typed into ChatGPT 4o and Google Gemini 2.5 (non-paid versions). For each question, a new chat was started to prevent any continuation of answers. Three reviewers independently reviewed the responses using two validated healthcare tools: DISCERN (quality) and Patient Education Material Assessment Tool (understandability and actionability). Results : Mean DISCERN scores (out of 80) were higher for Gemini than ChatGPT in all domains except “Other”. Prospective 49.2 vs 39.1; technical 52.3 vs 44.3; recovery 53.7 vs 45.4; other 54.3 vs 56.5; overall 52.4 vs 45.8 (Figure 1). PEMAT-P understandability uniformly exceeded 70% for both platforms: prospective 80.0% vs 71.7%; technical 80.1% vs 79.8%; recovery 79.2% vs 80.1%; other 79.2% vs 81.3%; overall 79.7% vs 78.1% (Figure 2). Actionability was uniformly low; only Gemini met 70% threshold in the prospective domain (Figure 3). Conclusion : ChatGPT and Gemini deliver relevant and understandable information related to urologic telesurgery, with Gemini more consistently providing sources. However, neither chatbot reliably offers actionable responses, limiting their utility as a standalone gateway for patient decision-making.

Article activity feed